rekovelle solution for injection 12mcg0.36ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 12.0mcg
rekovelle solution for injection 36mcg1.08ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 36.0 mcg
rekovelle solution for injection 72mcg2.16ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 72.0 mcg
bio-rad liquichek amh control
bio-rad laboratories (singapore) pte ltd - clinical chemistry - liquicheck amh control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for anti-mullerian hormone (amh)
zepatier
merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitis c, chronic - direct acting antivirals, antivirals for systemic use, , antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4.2, 4.4 and 5.1). for hepatitis c virus (hcv) genotype-specific activity see sections 4.4 and 5.1.,
beckman coulter access amh immunoassay system
beckman coulter singapore pte. ltd. - immunology - the access amh assay is a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of anti-müllerian hormone (amh) levels in human serum and plasma using the access immunoassay systems as an aid in the assessment of ovarian reserve.
beckman coulter amh gen ii elisa
beckman coulter singapore pte. ltd. - immunology - the anti-mullerian hormone (amh) gen ii enzyme linked immunosorbent assay (elisa) kit provides materials for the quantitative measurement of amh in human serum and lithium heparin plasma. this assay is intended for in vitro diagnostic use.
roche diagnostics elecsys amh plus
roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitive determination of amh in human serum and plasma. the determination of amh is used for the assessment of the oviran reserve and the prediction of response to controlled ovarian stimulation (cos) in conjunction with other clinical and laboratory findings. in addition, the determination of amh (in pmol/l) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rfsh) follitropin delta of ferring (in accordance with the current prescribing information of the ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.